A Proposal of a Personalized Surveillance Strategy for Gastric Cancer: A Retrospective Analysis of 9191 Patients

Figure 3

Conditional survivals from different intervals are compared for patients in the cohort differed from TNM stages during different periods: (a) three-month conditional survival (3mCS) and six-month conditional survival (6mCS) of stage I in the first 3 years after resection and (b) 6mCS and 12-month conditional survival (12mCS) in the latter 2 years were demonstrated, and all were at a high level of more than 94%; (c) 3mCS and 6mCS of stage II in the first 2 years and (d) 6mCS and 12mCS in the latter 3 years were demonstrated, and it showed a smaller gap of each pair in stage IIA than stage IIB; (e) 3mCS and 6mCS of stage III in the first 2 years and (f) 6mCS and 12mCS in the latter 3 years were demonstrated. Short intervals of follow-up showed significant superiority of CS in advance stages.

(a)

(b)

(c)

(d)

(e)

(f)